ResMed CEO Mick Farrell Balances Career, Family, and Bringing Tech, Software, and Data into Medtech

Medtech Podcast Episode 115

EPISODE 115

Mick Farrell’s father questioned his son’s double degree from MIT when he didn’t immediately see the opportunity facing the sleep apnea company. But the younger Farrell quickly came around and helped build ResMed into a $15 billion company, with the last five years at the helm as CEO. Today, however, Farrell has ResMed beginning to take a very different path, migrating away from pure medical device sales and into selling software and other tech services to physicians.

Podcast Guest

Mick Farrell

Mick Farrell

CEO

ResMed

Mick Farrell was appointed ResMed’s CEO in March 2013. He joined the company in 2000, serving as president of the Americas region from 2011 to 2013, senior vice president of the global sleep apnea business unit from 2007 to 2011, and various senior roles in marketing and business development.

Before joining ResMed, Mick worked in management consulting, biotechnology, chemicals and metals manufacturing at Arthur D. Little, Genzyme Corporation (now part of Sanofi), The Dow Chemical Company, and BHP Billiton.

Mick serves on the board of directors of ResMed, the Advanced Medical Technology Association (AdvaMed) and Zimmer Biomet (NYSE: ZBH), a multibillion dollar public company that provides implantable musculoskeletal medical devices for patients globally. He is also a member of two committees at Zimmer Biomet: Nominating and Governance as well as Compensation and Management Development. He also volunteers as a trustee for non-profit organizations: UC San Diego Foundation, Rady Children’s Hospital, the La Jolla Playhouse, and the Museum of Man in San Diego.

Mick holds a bachelor of engineering with first-class honors from the University of New South Wales, a Master of Science in chemical engineering from the Massachusetts Institute of Technology, and a Master of Business Administration from the MIT Sloan School of Management.

Do You Have

A STORY TO TELL?

If you’d like to be considered as a guest on a future episode of the Medtech Talk Podcast, please complete the application today.

Meet Our Host

TOM SALEMI

Tom Salemi

A follower and fan of medtech for nearly two decades, Tom Salemi is the former bureau chief, venture capital, at Elsevier Business Intelligence, where he oversaw coverage of venture investments in medtech.

Subscribe

ON iTUNES

Don't miss an episode. Join the conversation by visiting our podcast channel on iTunes today and subscribe. It's fast and free!